Skip to main content
. 2023 Feb 21;23:176. doi: 10.1186/s12885-023-10652-5

Fig. 1.

Fig. 1

MLXIPL is upregulated in HCC. (A) MLXIPL expression in tumor (n = 374) and normal control (n = 50) was predicted using the starBase database. MLXIPL in PCLT tissues and HCC tissues (n = 56) was measured using (B) qPCR. (C) The MLXIPL level in PCLT and HCC tissues were assessed by IHC assay and IHC score was quantified. (D) The survival rate of HCC patients with a high or low expression of MLXIPL. MLXIPL in THLE3, Hep3B, Huh7, Focus, and HA22T cells was measured using (E) qPCR and (F) western blot. **P < 0.01. *P < 0.05